News

Eviden and Serbia Collaborate on National AI Factory Initiative

Eviden and Serbia Collaborate on National AI Factory Initiative

Eviden and Serbia Collaborate on National AI Factory Initiative

Eviden, a leader in digital transformation and advanced technology, is set to revolutionize artificial intelligence capabilities in Serbia through a groundbreaking collaboration. This initiative will establish a National AI Factory that intertwines cutting-edge technology with government efforts to enhance Serbia's AI landscape.

The National AI Factory: A Comprehensive Vision

At the core of this initiative lies a €50 million investment aimed at developing a sophisticated AI ecosystem. This factory will not only house advanced computing power but also integrate various AI capabilities, including dedicated software and development of real-world AI applications. The goal is to drive innovation across critical sectors in Serbia by equipping local institutions, businesses, and universities with the necessary resources.

Understanding AI Infrastructure Beyond Simple Technology

Unlike traditional IT solutions, the National AI Factory is designed as a comprehensive infrastructure, providing a complete set of AI-dedicated assets. This includes access to talents, expertise, hardware, and software, all geared toward democratizing AI technology and driving massive-scale projects. Eviden’s approach will allow Serbia to meet the increasing demands for AI and tackle emerging challenges effectively.

Supercomputing Resources Empowering Innovation

This innovative facility will utilize the BullSequana XH3000 supercomputer, engineered in France, which can deliver up to 25 PetaFlops of computational power. This robust system will furnish essential computing capabilities to facilitate the development of groundbreaking AI projects and foster a strong foundation for Serbia as a leader in AI innovation.

Partnership Highlights for Serbia's Future

The collaboration promises to be transformative, positioning Serbia strategically within the global AI landscape. Through this partnership, Eviden is not just supplying technology; the company is committed to providing ongoing support for recruitment and training, ensuring that local engineers and academic professionals are fully equipped for the future.

Building a Self-Sustaining AI Ecosystem

Eviden will also aid in cultivating a self-sustaining AI hub in Serbia by leveraging its team of specialists, who will not only collaborate on AI projects but also ensure that knowledge transfer is maximized. This will fortify Serbia's position as a regional leader in areas such as healthcare, energy management, transportation, and administration.

Statements from Key Leaders

Mihailo Jovanovic, PhD, from Serbia’s Office for IT and eGovernment, expressed that this partnership marks a pivotal moment in Serbia’s digital advancement. The collaboration with Eviden exemplifies a commitment to fostering innovation and enhancing the economy, aligning with Serbia's vision for future modernization.

Emmanuel Le Roux, the Head of Advanced Computing at Eviden, emphasized that Serbia's proactive investment in AI research demonstrates its ambition in technological leadership. This collaboration is not merely about technology adoption; it symbolizes a significant leap towards economic and digital growth.

About Eviden

Eviden stands as a next-gen leader in trusted digital transformation, operating within Atos Group. It boasts a strong portfolio, focusing on advanced computing, security, and AI applications across 47 countries. With a workforce of 41,000 skilled professionals, Eviden is dedicated to expanding the potential of data across diverse industries.

Frequently Asked Questions

What is the purpose of the National AI Factory in Serbia?

The National AI Factory aims to boost Serbia's AI capabilities by providing advanced computing resources and fostering innovation across various sectors.

How much is Eviden investing in this initiative?

Eviden is committing €50 million towards the development of the National AI Factory in collaboration with Serbia’s government.

What technologies will be used in the AI Factory?

The facility will utilize advanced supercomputing resources, including the BullSequana XH3000 supercomputer, alongside bespoke AI applications and development platforms.

How will this initiative benefit Serbian professionals?

The project will facilitate training and knowledge sharing, empowering local engineers and academics in the field of AI.

What is the expected impact of this partnership on Serbia?

This collaboration is expected to position Serbia as a regional AI leader, promoting economic growth and enhancing technological autonomy through innovation.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Paulex Bio's PAL-119 Trials: A New Diabetes Frontier

Updated Category News Views 80

Chasing the Holy Grail in Diabetes Treatment The pursuit of a true remedy for diabetes is almost like hunting for the mythical beast—a challenge that's left plenty of contenders biting the dust over the years. Yet, here's Paulex Bio jumping right into the fray with their groundbreaking PAL-119. They're not just peddling another temporary fix like most on the market;...

Continue Reading
PRG Projects' London Studio Elevates Live Entertainment

Updated Category News Views 172

A New Stage for Creativity in London When the curtain rises on a fresh idea, it's often the unknowns that make or break a production. Now, with PRG Projects unveiling their spanking new Project Studio in London, the tech and creative worlds might just bridge their gap tighter than a stage curtain before showtime. London Welcomes PRG's Innovative Hub This isn't just...

Continue Reading
TriMas Streamlines Portfolio with Rapak Sale

Updated Category News Views 48

TriMas Sheds Rapak: A Strategic Move Here's a twist worth dissecting: TriMas Corporation (NASDAQ: TRS) has offloaded its subsidiary Rapak, LLC to the German industrial packaging giant, Ringmetall SE. This isn't just a business shuffle—it's a calculated pivot with eyes on sharpening the core business blade. As they announced from Bloomfield Hills, Michigan, this move...

Continue Reading
i-80 Gold's Q3 2026: Production Plans Unveiled

Updated Category News Views 31

Gold Miners on the Move: Eye on i-80 Wake up and smell the gold, folks. i-80 Gold is ramping up to increase its yearly gold production targets, aiming for a hefty 150,000 to 200,000 ounces by 2028. Now, if you’ve been around the block like me, you know these are the kind of numbers that get investors either shifting in their chairs or springing to their feet. A Brief...

Continue Reading
RD Technologies Ramps Up Cross-Border Payments

Updated Category News Views 185

RD Technologies: Revving Up the Payment Game RD Technologies is at it again, jazzing up its game in the cross-border payments realm. One can almost smell the digits doing a tango across continents—particularly as Hong Kong's financial warriors set their sights on beefing up trade between Africa and Asia. New Alliances in the Payment Arena Here's a roadmap: Connect the...

Continue Reading
Ascletis Showcases Bold Moves in Obesity Drug Arena

Updated Category News Views 163

If you’ve been watching the developments in the world of obesity treatments, Ascletis Pharma is a name you'd do well not to ignore. With ObesityWeek 2026 on the horizon, these folks aren’t just talking—they’re putting their preclinical cards on the table and they’re noteworthy. Unveiling Future Contenders Ascletis is gearing up to present some of their...

Continue Reading
Lincoln Avenue's Bold New Move: Affordable Senior Living

Updated Category News Views 33

A New Senior Housing Era Begins in Channahon If there's one thing the affordable housing game loves, it's the mix of ambition and grit—both of which Lincoln Avenue Communities (LAC) brings to the table with The Talia. This latest project in Channahon, Illinois, marks their fourth groundbreaking in the state, cementing LAC's place as a key player in providing quality...

Continue Reading
Kim Dunbar Sheds Light on Online Personalized Learning

Updated Category News Views 11

Picture a classroom without walls, the teacher always available, and students moving at their own pace. Sounds utopian, right? Well, Virtual Public School Expert Kim Dunbar is making sense of this approach at SC Whitmore School in Columbia, South Carolina, as she explains how this works in an online high school. Mastery-Based Learning: Beyond the Conventional Rigid...

Continue Reading
Neurocrine Biosciences Hits $1 Billion Mark in Q3 2026

Updated Category News Views 23

Neurocrine's Triple-Digit Surge Neurocrine Biosciences is on a tear, pushing its revenue up to a jaw-dropping $1.1 billion in Q3 2026—a hefty 41% leap from the previous year. Frankly, you can't ignore those numbers. INGREZZA, which is practically becoming a cash cow, did $801 million alone, rising 17% year over year. This rides the wave of prescription surges and solid...

Continue Reading
Dr. Huang's Honorary Degree Caps Global Impact Journey

Updated Category News Views 41

Recognition from Alma Mater Puts a Bow on a Storied Career When someone ventures out into the world and leaves a mark across continents, it’s a remarkable feat. It’s even more heartening when the place that helped shape them gets to extend a nod of recognition. Dr. Charles Huang, the mastermind behind Pasaca Capital, just unwound a new layer to his multicolored life...

Continue Reading
/neurocrine-biosciences-hits-1-billion-mark-in-q3-2026-540185-/" title="Neurocrine Biosciences Hits $1 Billion Mark in Q3 2026 - Continue Reading" aria-label="Continue reading: Neurocrine Biosciences Hits $1 Billion Mark in Q3 2026"> Continue Reading